Leslie L Trigg - 03 Jan 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
By: John L Brottem For: Leslie Trigg
Issuer symbol
OM
Transactions as of
03 Jan 2022
Net transactions value
-$1,836,663
Form type
4
Filing time
04 Jan 2022, 15:29:54 UTC
Previous filing
02 Dec 2021
Next filing
28 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $77,600 +20,000 +8% $3.88 270,567 03 Jan 2022 Direct
transaction OM Common Stock Sale $941,952 -20,000 -7.4% $47.10 250,567 03 Jan 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $48,500 +12,500 +5% $3.88 263,067 03 Jan 2022 Direct
transaction OM Common Stock Sale $588,745 -12,500 -4.8% $47.10 250,567 03 Jan 2022 Direct F1, F3
transaction OM Common Stock Options Exercise $38,800 +10,000 +4% $3.88 260,567 03 Jan 2022 Direct
transaction OM Common Stock Sale $470,866 -10,000 -3.8% $47.09 250,567 03 Jan 2022 Direct F1, F4
holding OM Common Stock 8,770 03 Jan 2022 Trigg Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -20,000 -13% $0.000000 138,211 03 Jan 2022 Common Stock 20,000 $3.88 Direct F5
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -12,500 -9% $0.000000 125,711 03 Jan 2022 Common Stock 12,500 $3.88 Direct F5
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -8% $0.000000 115,711 03 Jan 2022 Common Stock 10,000 $3.88 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 1,040 shares; $46.00-$46.99 - 3,779 shares; $47.00-$47.99 - 15,181 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 775 shares; $46.00-$46.99 - 1,691 shares; $47.00-$47.99 - 10,034 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 700 shares; $46.00-$46.99 - 1,784 shares; $47.00-$47.99 - 7,366; $48.00 - $48.99 - 150 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 This option vested in 48 equal monthly installments beginning on October 19, 2017.